Item 2. Properties
ITEM 2. PROPERTIES.
We lease property in multiple facilities across the U.S. and Italy, including facilities located in El Segundo and Culver City, CA that are leased from related parties. See Note 8 , Related-Party Agreements , of the “Notes to Consolidated Financial Statements” that appears in Part II, Item 8. “Financial Statements and Supplementary Data” of this Annual Report for additional information about our related-party leases.
The following table summarizes our principal properties under lease as of December 31, 2021:
Location Expiration
Year (1) Approximate
Rentable
Square Feet (2) Primary Function(s)
United States
El Segundo, CA 2023 - 2028
168,570 Laboratory - Research & Manufacturing
Louisville, CO 2025 50,838 Laboratory - Research & Manufacturing
San Diego, CA 2023 44,681 Laboratory - Research & Corporate Office
Culver City, CA Month to Month 9,500 Laboratory - Research & Manufacturing
Woburn, MA 2025 8,153 Laboratory - Research & Office
Seattle, WA 2025 5,527 Laboratory - Research
Miramar, FL 2025 2,571 Clinical Affairs & Office
International
Italy 2024 - 2027
11,313 Laboratory - Research & Office
_______________
(1) Expiration years shown are per the lease agreements in effect as of December 31, 2021 and do not reflect contractual options to extend the term of the lease available to us under the lease agreements. For locations with multiple leases, the first and last expiration year are shown.
(2) Amounts shown represent the total approximate rentable square feet for all buildings located in each city.
On February 14, 2022, we acquired a leasehold interest in approximately 409,000 rentable square feet of cGMP ISO Class 5 pharmaceutical manufacturing space in western New York (the Dunkirk Facility). This facility provides us with a state-of-the-art biotech production center that substantially expands and diversifies our existing manufacturing capacity in the U.S. See Note 13 , Subsequent Events , of the “Notes to Consolidated Financial Statements” that appears in Part II, Item 8. “Financial Statements and Supplementary Data” of this Annual Report.
We believe that our existing facilities are adequate to meet our current and future needs and that we will be able to renew existing leases and obtain additional commercial space as needed.
108
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.